Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Interest & Investment Income: 2010-2024

Historic Interest & Investment Income for Altimmune (ALT) over the last 13 years, with Dec 2024 value amounting to $8.1 million.

  • Altimmune's Interest & Investment Income rose 27.02% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 21.22%. This contributed to the annual value of $8.1 million for FY2024, which is 9.84% up from last year.
  • Per Altimmune's latest filing, its Interest & Investment Income stood at $8.1 million for FY2024, which was up 9.84% from $7.4 million recorded in FY2023.
  • Altimmune's Interest & Investment Income's 5-year high stood at $8.1 million during FY2024, with a 5-year trough of $203,000 in FY2021.
  • Its 3-year average for Interest & Investment Income is $6.1 million, with a median of $7.4 million in 2023.
  • As far as peak fluctuations go, Altimmune's Interest & Investment Income slumped by 61.76% in 2020, and later soared by 1,313.79% in 2022.
  • Yearly analysis of 5 years shows Altimmune's Interest & Investment Income stood at $322,514 in 2020, then crashed by 37.06% to $203,000 in 2021, then skyrocketed by 1,313.79% to $2.9 million in 2022, then skyrocketed by 156.13% to $7.4 million in 2023, then rose by 9.84% to $8.1 million in 2024.